PRL excess and functional blockade of dopaminergic tone are key mechanisms implied in the pathogenesis of weight gain and obesity frequently described in patients with prolactinomas (5–7). This evidence concerns the gene PRL and obesity due to melanocortin 4 receptor deficiency.